2022
DOI: 10.1002/cnma.202100453
|View full text |Cite
|
Sign up to set email alerts
|

Polyethylenimine Functionalized Ultrasmall Mesoporous Silica Nanoparticles for siRNA Delivery

Abstract: Small interfering RNA (siRNA) for gene therapy has attracted great attention. However, due to easy degradation and inaccessibility to the cells, the gene silencing efficiency is not always satisfactory. To overcome this hurdle, developing an excellent nanocarrier to deliver siRNA into cancer cells is crucial. Fluorescent mesoporous silica nanoparticles are considered to be a superb nanocarrier for siRNA delivery systems because of its negligible toxicity and good biocompatibility. Herein, we developed an effic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…This effect, although not detailed in depth, could be a consequence of the better hosting and protection of plasmids at the larger mesopores. In another contribution, Su, Deng and coworkers, studied the performance of ultrasmall MSNs for siRNA delivery employing PEI too [ 51 ]. Their nanosystem, with an overall size of less than 12 nm, showed good biocompatibility on cancerous HeLa cultures (up to 200 μg·mL −1 ) and up to 80% knockdown onto glyceraldehyde-3-phosphate dehydrogenase (GADPH) onto HEK-293T cells, suggesting a great transfection efficiency similar to the reference, Lipofectamine 2000.…”
Section: Development Of Silica-based Nanomedicines Using Therapeutic ...mentioning
confidence: 99%
“…This effect, although not detailed in depth, could be a consequence of the better hosting and protection of plasmids at the larger mesopores. In another contribution, Su, Deng and coworkers, studied the performance of ultrasmall MSNs for siRNA delivery employing PEI too [ 51 ]. Their nanosystem, with an overall size of less than 12 nm, showed good biocompatibility on cancerous HeLa cultures (up to 200 μg·mL −1 ) and up to 80% knockdown onto glyceraldehyde-3-phosphate dehydrogenase (GADPH) onto HEK-293T cells, suggesting a great transfection efficiency similar to the reference, Lipofectamine 2000.…”
Section: Development Of Silica-based Nanomedicines Using Therapeutic ...mentioning
confidence: 99%